• Home   /  
  • Archive by category "1"

Waite Pharmaceuticals Case Study


'); if (document.getElementById(activeButton)) { newdocument.write('

'); newdocument.write(document.getElementById('right').innerHTML); newdocument.write('

'); newdocument.write('

'); newdocument.write(document.getElementById('topSection').innerHTML); newdocument.write('

'); newdocument.write(''); if (activeButton == 'leftTeaching') { newdocument.write(document.getElementById(activeButton).innerHTML); newdocument.write(document.getElementById(activeButton + '2').innerHTML); } else { newdocument.write(document.getElementById(activeButton).innerHTML); } } else { newdocument.write("There is a problem with the print version of this page.  Please contact the Web Team") } newdocument.write("

The following resources provide examples of TGaS' thought leadership on a variety of pharmaceutical operations and business topics.

Showing 76 out of 76 available documents

Article, Learning & Development

October 2017


Study: The Evolution of Learning Engagement

LTEN

By Rich Waite, Vice President, Commercial Learning & Development

The learning and development industry has been talking about the importance of learner engagement for years, but how much progress has actually been made in driving highly engaging learning solutions?

 

Article, Pricing & Contract Management

July 2017


How Pricing & Contract Management Looks - From the Inside

Pharmaceutical Commerce

By Brian Deppen, Vice President, Pricing & Contract Management

In the latest issue of Pharmaceutical Commerce, Brian Deppen shares insights from TGaS' Future Issues in Contract Management 2016-2019 landscape study. Addressing the demands of customers-payers, PBM managers and others - remains the No. 1 priority of Pricing and Contract ...

Article, Market Access & Reimbursement

June 2017


A New Age of Payer Access

Med Ad New

In Med Ad News, Rebecca Villari discusses how manufacturers are responding to increasing pressure to demonstrate value and lower the cost of pharmaceuticals, particularly in today's uncertain health policy environment.

Article, TGaS Insights

December 2016


Trending 2017: The Cancer Moonshot

PharmaVOICE

By PharmaVOICE Staff

The historic collaboration initiative aims to accelerate the potential of immunotherapy as the next generation standard of care for cancer. Curt Staab, Vice President of Emerging Life Sciences Network for TGaS Advisors, provides insights and data on the cost of cancer therapies.

Article, TGaS Insights

December 2016


Trending 2017: Talent Wars

PharmaVOICE

By PharmaVOICE Staff

For sustainable success, companies need to create an experience and environment where employees want to show up, not necessarily where they need to show up. Tim Wohlgemut, Senior Vice President, TGaS Insights, a division of TGaS Advisors provides insights.

Article, Learning & Development

November 2016


The Smart Way: Doing More With Less

LTEN

By Kathryn Rebilas

Page 48. In our current world of cuts and consolidations, we might tire of hearing the old adage, "Do more with less." Yet, according to the latest data available from the 2016 LTEN/TGaS Advisors Pharmaceutical Training Landscape, pharma companies are doing just that. And making ...

Article, Emerging Life Sciences Network

October 2016


The Specialty Drug Market

PharmaVoice

As specialty drugs continue to earn a greater share of the pharmaceutical market, marketing, sales, and key opinion leader (KOL) professionals are faced with addressing market access issues, while needing to create an attractive value proposition for physicians. Curt Staab, Vice ...

Article, Market Access & Reimbursement

September 2016


4 Steps to Creating Compelling Payer Value Propositions

PM360

By Rebecca Villari, Executive Director, Market Access & Reimbursement

The economic buyer has emerged as a key stakeholder in market access. Payer value propositions must include evidence of both clinical and economic benefit that satisfies the needs of the provider from the perspective of improved care and the payer in terms of the total cost of ...

Article, TGaS Insights

September 2016


Moving From Big Pharma to a Small Company?

Pharmaceutical Commerce

By Tim Wohlgemut

Page 6. Executives looking for new opportunities are more than welcome at small companies. Both sides may have a few surprises in store. 

Article, Executive Commercial Operations

April 2016


Path to Compelling Payer Value Propositions Subject of New Report

PharmaVOICE

By PharmaVOICE

Effective payer value propositions are among the most pressing issues for biopharmaceutical companies across the board from large tier to startup. “Creating Compelling Payer Value Propositions” is an executive report issued by TGaS Insights, a service providing commercial leaders ...

Advisory Brief, Learning & Development

April 2016


Instructor-Led Virtual Classroom

LTEN

By Kathryn Rebilas

Page 49. In order to keep pace with the rapidly changing environment, instructor-led virtual classroom utilization is on the rise in the life sciences industry.

Article, Sales

March 2016


Preparing For An Outcomes-Based Sales Model

PharmaVOICE

Sales reps will need to broaden their focus to include other healthcare stakeholders, acquire new skills, learn to integrate digital technologies into their sales process and become part of the solution to improving patient outcomes.

Article, Learning & Development

February 2016


Market Access Training

PharmaVOICE

By Kathryn Rebilas

Page 40. Market Access Training is essential, and not just for those working directly with payers, institutions or government officials. 

Article, Sales

February 2016


PharmaTRAX: Biopharma Sales Operations Stabilizing

PharmaVOICE

By PharmaVOICE

Curt Staab, Vice President at TGaS Advisors provides thoughts on growth in sales operations spending driven by changing biopharma challenges and priorities.

Article, General

February 2016


Reflections and Predictions: Past, Present and Future

PharmVOICE

PharmaVOICE celebrates 15 years of trends with a look back at the market forces that have defined the industry and what's ahead as the healthcare ecosystem continues to be reinvented. TGaS associates provide their perspective.

Article, Commercial Analytics & Insights

December 2015


What is the Real Value of Market Research?

MM&M

By MM&M

With CPG companies experiencing continuing financial challenges, layoffs have begun, including significant numbers in the research function at major corporations. Is healthcare market research insulated from this trend? Anna McClafferty, SVP of Executive Commercial Operations at ...

Article, About TGaS

December 2015


Analytics Driven Marketing

PharmaVOICE

Ever-growing data and digital tools will enable smarter customer engagement. TGaS' Donna Wray is one of the thought leaders providing commentary.

Article, Learning & Development

September 2015


Medical Device Training Priorities-Global, Mobil, Advanced and Continuous

LTEN - Focus

By Kathryn Rebilas

Highlights from the 2015 Medical Device Landscape Study, reporting on issues such as strategic initiatives, trending topics and the time and topics being taught across sales representative, district manager and account manager curricula.

Article, About TGaS

July 2015


A Conversation with Gary McWalters

Pharmaceutical Commerce

TGaS makes the cover of Pharmaceutical Commerce! July-August issue features in-depth interview with Gary McWalters.

Article, Learning & Development

August 2014


Onboarding Training Programs

Focus Magazine

Assessing headquarters, regional and district onboarding programs and new training managers’ perspectives on the onboarding experience. ...

Article, Learning & Development

June 2014


Trends in Selling Models

Focus Magazine

By Rich Waite, Vice President, Commercial Learning & Development

The latest in selling model trends, how they are implemented and the impact on training and coaching responsibilities.

White Paper, Digital & Multichannel Marketing

March 2014


Multichannel Marketing: State of the Data

How companies deal with the process of managing new data and where they locate along the continuum from "Sparse Data" to "Big Smart Data."

Advisory Brief, Commercial Analytics & Insights

March 2014


Managing the New Mix

How companies are (or aren’t) using more sophisticated data and analytics as they wrestle with the challenges of multichannel marketing and the proliferation of new, nontraditional data.

Article, Learning & Development

March 2014


Moving from Reactive to Proactive

Focus Magazine

Moving from responding to training requests to knowing and anticipating marketing and sales training needs.

Article, Learning & Development

March 2014


Learning Management System Trends

Focus Magazine

By Rich Waite, Vice President, Commercial Learning & Development

How training organizations use dedicated learning management systems, what kinds of systems they use and experience with external Learning Management System (LMS)-hosted solutions.

Advisory Brief, Executive Commercial Operations

February 2014


Global Commercial Operations Landscape

TGaS® Advisors reaches out to U.S. and Global leaders of commercial operations departments to delve into what appeared to be a trend toward increasing globalization of commercial operations functions and and activities.

Article, Learning & Development

September 2013


Gamification: You May Already be a Winner!

Focus Magazine

By Rich Waite, Vice President, Commercial Learning & Development

Key trends in gamification, how many use it and implications for training organizations.

Article, Learning & Development

May 2013


Training and Technology: Leveraging the Power of Digital

PharmaVOICE

By Rich Waite, Vice President, Commercial Learning & Development

The innovative use of training technology is making profound changes the pharmaceutical industry. At the same time, day-to-day demands keep increasing, while shrinking budgets and limited resources add to the challenge. Training leaders must become more creative, leveraging techn ...

Article, Learning & Development

May 2013


Training: A New Way FORWARD

PharmaVOICE

By Rich Waite, Vice President, Commercial Learning & Development

Traditional training techniques, once centered on the learner's needs, are now being turned around to account for what's good for the business. Rich Waite and other industry experts provide their viewpoints.

Article, Learning & Development

March 2013


Social Media Tools in Training

Focus Magazine

By Rich Waite, Vice President, Commercial Learning & Development

Challenges to use of social media tools, compliance issues and demonstrating value.

Article, Sales

January 2013


Sales Operations: Strengthen Amid Tighter Budgeting

PharmaVOICE

In the midst of a changing commercial landscape, pharma sales operations leaders are striving to produce vibrant organizations that develop and reward team members.

Article, Sales

January 2013


Strengthen Amid Tighter Budgeting

By Curt Staab, Senior Vice President, Emerging Life Sciences Network

In the midst of a changing commercial landscape, pharma sales operations leaders are striving to produce vibrant organizations that develop and reward team members.

White Paper, Market Access & Reimbursement

November 2012


The Managed Markets Organization: A Function in Transition

By Joe Falcon, Senior Vice President, Market Access

The TGaS Managed Markets Practice sets out priorities and challenges faced by Managed Markets in working with Brand teams.

Article, Market Access & Reimbursement

October 2012


A Changing Mindset: Managing Managed Markets

PharmaVOICE

By Joe Falcon, Senior Vice President, Market Access

Joe Falcon is a featured expert in this article about what companies must do going forward to incorporate the payer perspective into brand strategy and demonstrate value from the very beginning.

Article, Med/Reg/Legal Review

April 2012


A Bridge to Better Outcomes

PharmaVOICE

By Jim Mercante

Medical Affairs, says Jim Mercante, who is quoted in this article, has become a global group serving as a conduit between internal stakeholders and their external clients.

Article, Digital & Multichannel Marketing

October 2011


Marketing on a Two-Way Street

PharmaVOICE

Donna Wray and other industry experts provide their views on the cost of avoiding social media as well as the importance of the business justification for doing so.

Article, Executive Commercial Operations

June 2011


Fact vs. Fiction

Pharmaceutical Commerce

Industry observers invariably describe the commercial model as broken. A new TGaS study reveals what's really happening, says Anna McClafferty.

Landscape Study, Executive Commercial Operations

April 2011


The New Commercial Model: Reality or Rhetoric?

TGaS Landscape Study, sorting fact from fiction in this look at the drivers of change and the demands of the new commercial models.

Article, Learning & Development

April 2011


Reinventing Training & Development

Pharmaceutical Representative

By John Carro, Senior Vice President, Executive Commercial Operations

In a rapidly evolving commercial environment, training departments would do well to go back to the drawing board, say TGaS Training & Development specialists.

Article, Learning & Development

April 2011


Sales Training in Transition

PharmaVOICE

As traditional sales reps roles shift, training models must evolve accordingly. TGaS contributes "5 Steps to Reinventing Training & Development" to this article.

Article, Executive Commercial Operations

July 2010


The Five Things We Need to Do to Re-invent Commercial Operations

Pharmaceutical Commerce

By Stephen Gerard, Chief Executive Officer & Executive Chairman

By running commercial operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance.

Advisory Brief, Digital & Multichannel Marketing

February 2010


TGaS Advisors Comments to FDA on Social Media

This summary of opinions on FDA areas of inquiry are based on our experience, data and comments from our member companies, including GlaxoSmithKline, Novo Nordisk, Ortho-McNeil Janssen, Sanofi-aventis, Shire, Takeda, and others.

Article, Executive Commercial Operations

November 2008


Pharma Be Nimble. Quick!

Pharmaceutical Executive

TGaS Advisors was part of a select group of 8 consultants asked to share their ideas on the ever-changing environment.

To top

One thought on “Waite Pharmaceuticals Case Study

Leave a comment

L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *